Pfizer, the renowned New York drugmaker, has successfully obtained all necessary regulatory approvals for its groundbreaking $43 billion acquisition of the biotech cancer specialist, Seagen. The company is now poised…
Shares of Pfizer, the healthcare giant, fell 3.5% to $31.00 in after-hours trading as the company significantly reduced its outlook for the year. The revision is primarily driven by expectations…
Pfizer announced on Friday that the Food and Drug Administration (FDA) has granted approval for its latest ulcerative colitis medication, etrasimod, to be marketed under the name Velsipity. Expanding Product…
Pfizer and BioNTech have received important regulatory approval from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for their updated version of the Comirnaty Covid-19 vaccine.…
(Pfizer) Shares of Biohaven Pharmaceutical rose more than 72% in premarket on Tuesday after news Pfizer will acquire it for $11.6 billion in cash. The deal values Biohaven at $148.50,…
(Pfizer) Pfizer expects lower revenues in FY22 than previously guided, despite reporting an 82% growth in first quarter revenue to $25.7 billion. Pfizer said that the stronger revenues in the…
(Myovant) Shares of Myovant Sciences fell more than 19% on Tuesday after the US Food and Drug Administration cited deficiencies in filing for an endometriosis drug. FDA did not offer…
(Pfizer) Shares of Pfizer Inc. plunged more than 4% on Tuesday after the biotech company raised its vaccine sales by $1 billion to $32 billion in FY22, below forecasts of…
(Pfizer) Pfizer Inc. is expecting to acquire drugmaker Arena Pharmaceuticals in a cash deal valued at $6.7 billion. The addition of Arena expands Pfizer’s product portfolio, with the target known…
(NBC News) Researchers drawn from the Africa Health Research Institute have found about a fortyfold reduction in Pfizer-BioNTech vaccine-induced antibodies against the Omicron Covid variant. The researchers found that Omicron…
(WSJ) S&P 500 futures fell about 1.6%, while the Dow Jones Industrial Average traded 2.2% lower on Friday on fresh concerns of the spread of a new strain of coronavirus…
(Pfizer) Pfizer Inc. has agreed to supply the US government with 10 million treatment courses of PAXLOVID, an oral antiviral drug candidate against Covid-19. The treatment courses will be delivered…